Manulife (Manufacturers Life Insurance)’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $436K | Buy |
13,194
+3,850
| +41% | +$163K | ﹤0.01% | 2216 |
|
|
2025
Q4 | $433K | Sell |
9,344
-1,167
| -11% | -$48.8K | ﹤0.01% | 2238 |
|
|
2025
Q3 | $368K | Sell |
10,511
-885
| -8% | -$30.8K | ﹤0.01% | 2319 |
|
|
2025
Q2 | $337K | Sell |
11,396
-106
| -0.9% | -$3.02K | ﹤0.01% | 2343 |
|
|
2025
Q1 | $343K | Sell |
11,502
-3,338
| -22% | -$102K | ﹤0.01% | 2298 |
|
|
2024
Q4 | $425K | Sell |
14,840
-311
| -2% | -$10.3K | ﹤0.01% | 2312 |
|
|
2024
Q3 | $585K | Sell |
15,151
-816
| -5% | -$29.1K | ﹤0.01% | 2197 |
|
|
2024
Q2 | $514K | Buy |
15,967
+199
| +1% | +$6.9K | ﹤0.01% | 2208 |
|
|
2024
Q1 | $612K | Buy |
15,768
+2,362
| +18% | +$82.6K | ﹤0.01% | 2116 |
|
|
2023
Q4 | $413K | Sell |
13,406
-266
| -2% | -$6.66K | ﹤0.01% | 2257 |
|
|
2023
Q3 | $306K | Hold |
13,672
| – | – | ﹤0.01% | 2371 |
|
|
2023
Q2 | $294K | Buy |
13,672
+405
| +3% | +$9.2K | ﹤0.01% | 2380 |
|
|
2023
Q1 | $318K | Hold |
13,267
| – | – | ﹤0.01% | 2266 |
|
|
2022
Q4 | $308K | Sell |
13,267
-173
| -1% | -$3.49K | ﹤0.01% | 2290 |
|
|
2022
Q3 | $215K | Sell |
13,440
-229
| -2% | -$4.04K | ﹤0.01% | 2544 |
|
|
2022
Q2 | $242K | Sell |
13,669
-762
| -5% | -$12.8K | ﹤0.01% | 2524 |
|
|
2022
Q1 | $294K | Sell |
14,431
-3,892
| -21% | -$73.5K | ﹤0.01% | 2527 |
|
|
2021
Q4 | $342 | Sell |
18,323
-651
| -3% | -$12.7K | ﹤0.01% | 2521 |
|
|
2021
Q3 | $375K | Sell |
18,974
-1,407
| -7% | -$30.4K | ﹤0.01% | 2497 |
|
|
2021
Q2 | $482K | Buy |
20,381
+495
| +2% | +$11.4K | ﹤0.01% | 2462 |
|
|
2021
Q1 | $471K | Sell |
19,886
-1,116
| -5% | -$26.5K | ﹤0.01% | 2312 |
|
|
2020
Q4 | $421K | Buy |
21,002
+900
| +4% | +$17.6K | ﹤0.01% | 2303 |
|
|
2020
Q3 | $419K | Sell |
20,102
-519
| -3% | -$9.37K | ﹤0.01% | 2086 |
|
|
2020
Q2 | $353K | Buy |
20,621
+39
| +0.2% | +$764 | ﹤0.01% | 2141 |
|
|
2020
Q1 | $336K | Buy |
20,582
+901
| +5% | +$18.6K | ﹤0.01% | 2031 |
|
|
2019
Q4 | $405K | Sell |
19,681
-1,285
| -6% | -$21.4K | ﹤0.01% | 2170 |
|
|
2019
Q3 | $240K | Hold |
20,966
| – | – | ﹤0.01% | 2454 |
|
|
2019
Q2 | $276K | Buy |
20,966
+10,048
| +92% | +$134K | ﹤0.01% | 2407 |
|
|
2019
Q1 | $165K | Buy |
+10,918
| New | +$175K | ﹤0.01% | 2483 |
|
|
2018
Q4 | – | Sell |
-11,068
| Closed | -$163K | – | 2549 |
|
|
2018
Q3 | $163K | Sell |
11,068
-11,059
| -50% | -$196K | ﹤0.01% | 2814 |
|
|
2018
Q2 | $527K | Buy |
22,127
+3,289
| +17% | +$80.9K | ﹤0.01% | 2343 |
|
|
2018
Q1 | $481K | Sell |
18,838
-838
| -4% | -$20K | ﹤0.01% | 2361 |
|
|
2017
Q4 | $363K | Buy |
19,676
+1,487
| +8% | +$21.3K | ﹤0.01% | 2547 |
|
|
2017
Q3 | $191K | Sell |
18,189
-432
| -2% | -$4.76K | ﹤0.01% | 3014 |
|
|
2017
Q2 | $233K | Buy |
18,621
+5,167
| +38% | +$51.1K | ﹤0.01% | 2884 |
|
|
2017
Q1 | $135K | Buy |
13,454
+2,346
| +21% | +$34.9K | ﹤0.01% | 3047 |
|
|
2016
Q4 | $173K | Buy |
11,108
+3,555
| +47% | +$59.1K | ﹤0.01% | 2895 |
|
|
2016
Q3 | $146K | Sell |
7,553
-2,815
| -27% | -$33.4K | ﹤0.01% | 2998 |
|
|
2016
Q2 | $123K | Buy |
10,368
+5,418
| +109% | +$89.5K | ﹤0.01% | 3113 |
|
|
2016
Q1 | $84K | Buy |
4,950
+3,667
| +286% | +$66.7K | ﹤0.01% | 3124 |
|
|
2015
Q4 | $35 | Buy |
+1,283
| New | +$27K | ﹤0.01% | 3324 |
|
Other funds holding COLL
EAM
VCM
Manulife (Manufacturers Life Insurance)'s COLL Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) increased its Collegium Pharmaceutical (COLL) stake by 41% in Q1 2026, buying an estimated $163K and bringing the position to 13,194 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #2216.
Manulife (Manufacturers Life Insurance) first reported a position in COLL in Q4 2015 and has held it in 41 quarters since. The position peaked at $612K in Q1 2024. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 13,194 shares of Collegium Pharmaceutical worth $436K as of Q1 2026.
- Manulife (Manufacturers Life Insurance) bought 3,850 Collegium Pharmaceutical shares in Q1 2026, an estimated $163K.
- Collegium Pharmaceutical made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2216 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Collegium Pharmaceutical in Q4 2015 and has held it in 41 quarters since.
- Manulife (Manufacturers Life Insurance)'s Collegium Pharmaceutical position peaked at $612K in Q1 2024.
- 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.